GPX4 and neoplasm: Administration of dihydroorotate or orotate, the substrate or product of DHODH, respectively, can attenuate or potentiate the ferroptosis induced by GPX4 inhibition, especially evident in tumor cells expressing low levels of GPX4 [30].